Apotea ABOMXSTO: APOTEA

APOTEA: Q1 2026 delivered strong growth, higher margins, and a solid net cash position

· Issued by Apotea AB

On 6ix: 6ix.com/news/apotea-q1-2026-delivered-strong-growth-higher-margins-and-a-solid-net-cash-position

Watch Apotea's latest callApotea (Stockholm:APOTEA) Q3 2026 Earnings Call · Replay · Nov 5Read the transcript of Apotea (Stockholm:APOTEA) Q3 2026 Earnings Call

Q1 2026 saw 10.5% revenue growth and a 5.2% EBIT margin, driven by Rx and OTC segments, improved gross margin, and strong cash flow. Investments focused on scaling Varberg and launching apotea.no.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Apotea AB on 6ix

In the deck

Earlier from Apotea

Later from Apotea

All Apotea news releases